Alison Muir

Alison Muir

Auto-generated profile, based on publicly available information

Alison Muir

Royal Victoria Hospital, Belfast, United Kingdom (P.B., A.M.).

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
BEBode Ensam
Bode Ensam
CCChristopher Cheung
Christopher Cheung
FAFahad Almehmadi
Fahad Almehmadi
BWBo Gregers Winkel
Bo Gregers Winkel
CSChiara Scrocco
Chiara Scrocco
EBElijah R. Behr
Elijah R. Behr
Background: The implications of a drug-induced type 1 Brugada ECG pattern following sodium channel blocker provocation (SCBP) are not fully understood. Methods: Baseline clinical and ECG data were obtained from consecutive unexplained cardiac arrest survivors undergoing SCBP at 3 centers. A further 15 SCBP positive (SCBP+) unexplained cardiac arrest survivors were recruited from 3 additional centers to explore ventricular fibrillation recurrence. Results: A total of 121 consecutive unexplained cardiac arrest survivors underwent SCBP. The yield of the drug-induced type 1 Brugada ECG pattern was 17%. A baseline type 2/3 Brugada pattern (T2/3BP) (adjusted odds ratio, 19.36 [2.74–136.61]; P =0.003) and PR interval (odds ratio, 1.03 [1.01–1.05] per ms; P =0.017) were independent predictors of SCBP+ response. A pathogenic SCN5A variant was identified in 36% of the SCBP+ group versus 0% in the SCBP− group ( P <0.001). Amongst SCBP+ patients, a spontaneous type 1 Brugada pattern was identified in 19% during follow up and in 24% a type 1 Brugada pattern was identified in a relative. Prior syncope (adjusted hazard ratio, 3.83 [1.36–10.78]; P =0.011) and the presence of global early repolarization (hazard ratio, 7.91 [3.22–19.44]; P <0.001) were independent predictors of 5-year ventricular fibrillation recurrence. There was a nonsignificant trend toward greater 5-year ventricular fibrillation recurrence in the SCBP− group (23/95 [24%] versus 3/34 [9%]; P =0.055). Conclusions: The yield of the drug-induced type 1 Brugada ECG pattern in consecutive unexplained cardiac arrest survivors undergoing SCBP is 17%. A baseline T2/3BP and PR interval were independent predictors of the drug-induced type 1 Brugada ECG pattern. Greater heritability of BrS phenotype in this group was evidenced by a greater prevalence of pathogenic SCN5A variants and relatives with a type 1 Brugada pattern. A history of prior syncope and the presence of global early repolarization were independent predictors of ventricular fibrillation recurrence.

2 August 2013 in Biomarkers in Medicine
Verified
Journal Article
Closed access
AMAlison R Muir
Alison R Muir
IMIan Ba Menown
Ian Ba Menown

18 May 2023 in Heart Rhythm
Verified
Journal Article
Open access
YWYanushi D. Wijeyeratne
Yanushi D. Wijeyeratne
MTMichael WT Tanck
Michael WT Tanck
JBJulien Barc
Julien Barc
AMAlison Muir
Alison Muir
TATakeshi Aiba
Takeshi Aiba
EBElijah Behr
Elijah Behr

8 February 2023 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
KLKatie Linden
Katie Linden
AMAlison Muir
Alison Muir
JMJoanne McOsker
Joanne McOsker